A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

NCT00165451 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Thalidomide
DRUG: Celecoxib
DRUG: Etoposide
DRUG: Cyclophosphamide

Sponsor

Dana-Farber Cancer Institute